![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](bt6722contents.gif)
Acta Cryst. (2005). E61, m1915-m1917 [ doi:10.1107/S1600536805027418 ]
-2-(1-butylbenzimidazol-2-yl)phenolato]-1
N3:2
O;1
O:2
N3-bis{[2-(1-butylbenzimidazol-2-yl)phenolato-
2N3,O]zinc(II)} 2-(1-butylbenzimidazol-2-yl)phenol disolvateAbstract: The centrosymmetric dinuclear title compound, [Zn2(C17H17N2O)4]·2C17H18N2O, has one 2-(1-butylbenzimidazol-2-yl)phenolate acting as a chelating ligand and the other as a bridging ligand, conferring a tetrahedral geometry on the Zn atom. The uncoordinated 2-(1-butylbenzimidazol-2-yl)phenol molecule interacts with the O atom of the chelating anion through a hydrogen bond.
Online 7 September 2005
Copyright © International Union of Crystallography
IUCr Webmaster